Search Results - "Shigefuku, Ryuta"

Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma by Tamai, Yasuyuki, Iwasa, Motoh, Eguchi, Akiko, Shigefuku, Ryuta, Sugimoto, Kazushi, Hasegawa, Hiroshi, Takei, Yoshiyuki

“…Background Copper (Cu) and zinc (Zn) are essential nutrients and cofactors of enzymatic reactions with their binding partner. Metallothionein (MT) plays an…”
Get full text

Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans by Tamai, Yasuyuki, Eguchi, Akiko, Shigefuku, Ryuta, Kitamura, Hiroshi, Tempaku, Mina, Sugimoto, Ryosuke, Kobayashi, Yoshinao, Iwasa, Motoh, Takei, Yoshiyuki, Nakagawa, Hayato

“…Background: Hepatic sarcopenia is one of many complications associated with chronic liver disease (CLD) and has a high mortality rate; however, the…”
Get full text

A Rare Presentation of Intraperitoneal Ectopic Varices Rupture by Shigefuku, Ryuta, Iwasa, Motoh, Yoshikawa, Kyoko, Takei, Yoshiyuki

Get full text

Serum Copeptin and Zinc-α2-glycoprotein Levels Are Novel Biomarkers of Tolvaptan Treatment in Decompensated Cirrhotic Patients with Ascites by Shigefuku, Ryuta, Iwasa, Motoh, Eguchi, Akiko, Tempaku, Mina, Tamai, Yasuyuki, Suzuki, Tatsuya, Takei, Yoshiyuki

“…Objective The efficacy of tolvaptan, an orally active vasopressin V2-receptor antagonist, has recently been reported in patients with massive ascites…”
Get full text

Accuracy of carbohydrate‐deficient transferrin as a biomarker of chronic alcohol abuse during treatment for alcoholism by Suzuki, Tatsuya, Eguchi, Akiko, Shigefuku, Ryuta, Nagao, Saeko, Morikawa, Masayuki, Sugimoto, Kazushi, Iwasa, Motoh, Takei, Yoshiyuki

“…Aim Clinical evaluations are generally used to verify the effectiveness of detoxification treatments for alcohol dependence, but new objective biomarkers are…”
Get full text

Hepatocellular Carcinoma Pseudoprogression Involving the Main Portal Vein, Right Ventricular Invasion, and Exacerbation of Lung Metastases in a Patient on Atezolizumab Plus Bevacizumab by Shigefuku, Ryuta, Yoshikawa, Kyoko, Tsukimoto, Mone, Owa, Hirono, Tamai, Yasuyuki, Tameda, Masahiko, Ogura, Suguru, Sugimoto, Ryosuke, Tanaka, Hideaki, Eguchi, Akiko, Sugimoto, Kazushi, Hasegawa, Hiroshi, Iwasa, Motoh, Nakagawa, Hayato

“…A 70-year-old man was diagnosed with hepatocellular carcinoma (HCC) with portal vein invasion and lung metastases, for which atezolizumab plus bevacizumab…”
Get full text

Serum Zinc-α2-glycoprotein Levels Are Associated with the Hepatorenal Function and Predict the Survival in Cases of Chronic Liver Disease by Shigefuku, Ryuta, Iwasa, Motoh, Eguchi, Akiko, Tempaku, Mina, Tamai, Yasuyuki, Fujiwara, Naoto, Sugimoto, Ryosuke, Tanaka, Hideaki, Sugimoto, Kazushi, Kobayashi, Yoshinao, Nakagawa, Hayato

“…Objective Zinc-α2-glycoprotein (ZAG) is secreted by various organs, such as liver, kidney and adipose tissue, is involved in lipolysis, and may contribute to…”
Get full text

Recurrent hepatocellular carcinoma with osteoclast-like giant cells: a case report by Tsukimoto, Mone, Sugimoto, Kazushi, Shigefuku, Ryuta, Sugimoto, Ryosuke, Yuasa, Hiroto, Uchida, Katsunori, Yamamoto, Norihiko

“…Hepatocellular carcinoma with osteoclast-like giant cells is very rare and has an extremely poor prognosis. Here, we report a case of hepatocellular carcinoma…”
Get full text

Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience by Iwasa, Motoh, Shigefuku, Ryuta, Eguchi, Akiko, Tamai, Yasuyuki, Takei, Yoshiyuki

“…Liver cirrhosis is the final stage of chronic liver disease (CLD) and is associated with high morbidity and mortality. Various complications such as portal…”
Get full text

Effects of endoscopic injection sclerotherapy for esophagogastric varices on portal hemodynamics and liver function by Shigefuku, Ryuta, Takahashi, Hideaki, Watanabe, Tsunamasa, Hattori, Nobuhiro, Ikeda, Hiroki, Matsunaga, Kotaro, Ehira, Takuya, Suzuki, Tatsuya, Matsumoto, Nobuyuki, Okuse, Chiaki, Iwasa, Motoh, Nakagawa, Hayato, Itoh, Fumio, Suzuki, Michihiro

“…Abstract Objectives To identify patients suitable for endoscopic injection sclerotherapy (EIS) by evaluating their portal hemodynamics and liver function…”
Get full text

The prognostic potential of fragmented CK18 serum levels in HCC patients reflecting disease progression and overall hepatocyte damage by Eguchi, Akiko, Iwasa, Motoh, Tamai, Yasuyuki, Yamada, Minori, Okuno, Koji, Shigefuku, Ryuta, Yoshikawa, Kyoko, Tempaku, Mina, Sakaguchi, Koji, Tanaka, Hideaki, Sugimoto, Kazushi, Kobayashi, Yoshinao, Yamaguchi, Tetsuji, Nakagawa, Hayato

“…Background Fragmented cytokeratin 18 (fCK18) is released from damaged hepatocytes undergoing apoptosis and is recognized as a liver condition biomarker. We…”
Get full text

Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients by Sugimoto, Ryosuke, Iwasa, Motoh, Eguchi, Akiko, Tamai, Yasuyuki, Shigefuku, Ryuta, Fujiwara, Naoto, Tanaka, Hideaki, Kobayashi, Yoshinao, Ikoma, Jiro, Kaito, Masahiko, Nakagawa, Hayato

“…Pemafibrate is a selective peroxisome proliferator-activated receptor α modulator that improves serum alanine aminotransferase (ALT) in dyslipidemia patients…”
Get full text

Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus‐related liver cirrhosis by Shigefuku, Ryuta, Iwasa, Motoh, Katayama, Kazuhiro, Eguchi, Akiko, Kawaguchi, Takumi, Shiraishi, Koichi, Ito, Toshifumi, Suzuki, Kazutomo, Koreeda, Chizu, Ohtake, Takaaki, Tokumoto, Yoshio, Endo, Ryujin, Kawamura, Naohiro, Shiraki, Makoto, Habu, Daiki, Sakai, Hironori, Kato, Akinobu, Nishiguchi, Shuhei, Moriwaki, Hisataka, Suzuki, Kazuyuki, Takei, Yoshiyuki

“…Aim Hypozincemia is associated with the progression of chronic liver diseases, but it is unknown whether hypozincemia promotes human hepatocarcinogenesis. Our…”
Get full text

Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy by Tamai, Yasuyuki, Iwasa, Motoh, Eguchi, Akiko, Shigefuku, Ryuta, Kamada, Yoshihiro, Miyoshi, Eiji, Takei, Yoshiyuki

“…Rifaximin (RFX) treatment can attenuate not only hyperammonemia but also Enterococcus faecalis translocation and 10‐7G values, suggesting that RFX treatment…”
Get full text

Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C Virus by Shigefuku, Ryuta, Takahashi, Hideaki, Nakano, Hiroyasu, Watanabe, Tsunamasa, Matsunaga, Kotaro, Matsumoto, Nobuyuki, Kato, Masaki, Morita, Ryo, Michikawa, Yousuke, Tamura, Tomohiro, Hiraishi, Tetsuya, Hattori, Nobuhiro, Noguchi, Yohei, Nakahara, Kazunari, Ikeda, Hiroki, Ishii, Toshiya, Okuse, Chiaki, Sase, Shigeru, Itoh, Fumio, Suzuki, Michihiro

“…The progression of chronic liver disease differs by etiology. The aim of this study was to elucidate the difference in disease progression between chronic…”
Get full text

Elevation of enterococcus-specific antibodies associated with bacterial translocation is predictive of survival rate in chronic liver disease by Iwasa, Motoh, Eguchi, Akiko, Tamai, Yasuyuki, Shigefuku, Ryuta, Nakagawa, Ryo, Hasegawa, Hiroshi, Kondo, Jumpei, Morikawa, Masayuki, Miyoshi, Eiji, Nakagawa, Hayato

“…Introduction/purpose The gut-liver axis contributes to disease progression, a rise in infection rate, organ failure and a poor overall outcome in chronic liver…”
Get full text

Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study by Atsukawa, Masanori, Tsubota, Akihito, Kondo, Chisa, Koyano, Kaori-Shioda, Ishikawa, Toru, Toyoda, Hidenori, Takaguchi, Koichi, Watanabe, Tsunamasa, Matsuura, Kentaro, Ogawa, Chikara, Hiraoka, Atsushi, Okubo, Hironao, Tateyama, Masakuni, Uojima, Haruki, Nozaki, Akito, Chuma, Makoto, Kato, Keizo, Mikami, Shigeru, Tani, Joji, Morishita, Asahiro, Kawata, Kazuhito, Tada, Toshifumi, Furuichi, Yoshihiro, Okubo, Tomomi, Kawano, Tadamichi, Arai, Taeang, Kawabe, Naoto, Kawamura, Naohiro, Ikegami, Tadashi, Nakamuta, Makoto, Shigefuku, Ryuta, Iwasa, Motoh, Tanaka, Yasuhito, Hatano, Masaru, Iwakiri, Katsuhiko

“…Background Tricuspid regurgitation pressure gradient (TRPG) measurement by echocardiography is recommended as the most objective examination to detect…”
Get full text

Correlation between hepatic blood flow and liver function in alcoholic liver cirrhosis by Takahashi, Hideaki, Shigefuku, Ryuta, Yoshida, Yoshihito, Ikeda, Hiroki, Matsunaga, Kotaro, Matsumoto, Nobuyuki, Okuse, Chiaki, Sase, Shigeru, Itoh, Fumio, Suzuki, Michihiro

“…AIM:To elucidate the correlation between hepatic blood flow and liver function in alcoholic liver cirrhosis(AL-LC).METHODS:The subjects included 35 patients…”
Get full text

Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis? by Shigefuku, Ryuta, Takahashi, Hideaki, Kobayashi, Minoru, Ikeda, Hiroki, Matsunaga, Kotaro, Okuse, Chiaki, Matsumoto, Nobuyuki, Maeyama, Shiro, Sase, Shigeru, Suzuki, Michihiro, Itoh, Fumio

“…Introduction Effective noninvasive tests that can distinguish early-stage nonalcoholic steatohepatitis (NASH) from simple steatosis (SS) have long been sought…”
Get full text

Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b by Matsumoto, Nobuyuki, Ikeda, Hiroki, Shigefuku, Ryuta, Hattori, Nobuhiro, Watanabe, Tsunamasa, Matsunaga, Kotaro, Hiraishi, Tetsuya, Tamura, Tomohiro, Noguchi, Yohei, Fukuda, Yasunobu, Ishii, Toshiya, Okuse, Chiaki, Sato, Akira, Suzuki, Michihiro, Itoh, Fumio

“…Decreased hemoglobin (Hb) level has been supposed to be a relatively rare side effect of a combination therapy against hepatitis C virus that consists of the…”
Get full text